Multifocal tDCS in patients with Parkinson's Disease

Not Applicable

• Conditions: G20; Parkinson disease

• Registration Number: DRKS00026640
• Lead Sponsor: Charité Campus Charité Mitte

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-20
• Study Completion: 2022-09-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

Patients with Parkinson's disease, age 40-70 years, informed consent

Exclusion Criteria

Pronounced concomitant psychiatric symptoms (dementia symptoms, affective disorder), metal implants in the head, pacemaker, acute eczema of the scalp, known epilepsy, pregnancy, sensorineural hearing prosthesis, marked limitations of cognitive functions and verbal utterance

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in UPDRS-III as well as amplitude and velocity of diadochokinesis. Values will be compared to measurements on day of sham stimulation.

Secondary Outcome Measures

Name	Time	Method
Subjective perception of the patients about the effect of the stimulation written in a scale (0-10)